Recurrent Parathyroid Carcinoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Recurrent Parathyroid Carcinoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Recurrent Parathyroid Carcinoma trials you may qualify forThe purpose of this study is to look for an improvement in progression free survival with the combination of pemetrexed, carboplatin (or cisplatin) and cetuxima…
The purpose of this trial is to estimate progression free survival in patients with recurrent or metastatic head and neck cancer that have not received chemothe…
Interleukin-12 may kill tumor cells by stopping blood flow to the tumor and by stimulating a person's white blood cells to kill cancer cells. Monoclonal antibod…